Brief: A1M Pharma Receives Observation Status On Nasdaq First North

Disruptive Pharma AB (publ)

22/11/2018 13:20

Nov 22 (Reuters) - A1M Pharma AB  A1M.ST :
    * A1M PHARMA RECEIVES OBSERVATION STATUS ON NASDAQ FIRST NORTH
    * CO YESTERDAY PUBLISHED ITS INTERIM REPORT FOR Q3 OF 2018 WITH INFORMATION ON ITS FINANCIAL
SITUATION
    * IS IN A PROCESS TO SECURE COMPANY'S CONTINUED FUNDING
    * EXPECTS TO BE ABLE TO PRESENT A SOLUTION TO STRENGTHEN ITS WORKING CAPITAL IN COMING WEEKS

Source text for Eikon:  ID:nBQN4N5Yvd 
Further company coverage:  A1M.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))